IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting
Mireille Porter, Phuti Choshi, Sarah Pedretti, Tafadzwa Chimbetete, Rhodine Smith, Graeme Meintjes, Elizabeth J. Phillips, Rannakoe Lehloenya, Jonny Peter
Topics & Concepts
ELISPOTMedicineAdverse effectToxic epidermal necrolysisRifampicinImmunologyClofazimineEthambutolPyrazinamidePharmacologyInternal medicineDermatologyTuberculosisPathologyImmune systemLeprosyCD8Drug-Induced Adverse ReactionsAutoimmune Bullous Skin DiseasesImmunodeficiency and Autoimmune Disorders